BCDA Insider Trading Activity and SEC Form 4 Filings
BCDA insider trading summary
Over the past 12 months, insiders at BioCardia, Inc. (BCDA) reported 32 open-market purchases worth $169K by 2 insiders and no sales on SEC Form 4. Net insider buying was $169K.
Latest BCDA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Peter Altman | President and CEO | Buy | $285 (300 @ $0.95) |
| Oct 15, 2026 | Peter Altman | President and CEO | Buy | $190 (200 @ $0.95) |
| Sep 29, 2026 | Peter Altman | President and CEO | Buy | $1K (1,000 @ $1.03) |
| Sep 23, 2026 | Peter Altman | President and CEO | Buy | $2K (1,900 @ $1.05) |
| Sep 3, 2026 | Peter Altman | President and CEO | Buy | $872 (800 @ $1.09) |
| Aug 17, 2026 | Peter Altman | President and CEO | Buy | $5K (5,400 @ $0.93) |
| Aug 13, 2026 | Peter Altman | President and CEO | Buy | $2K (1,900 @ $0.92) |
| Jul 29, 2026 | Peter Altman | President and CEO | Buy | $4K (5,000 @ $0.78) |
| Jul 17, 2026 | Peter Altman | President and CEO | Buy | $415 (500 @ $0.83) |
| Jul 15, 2026 | Peter Altman | President and CEO | Buy | $1K (1,500 @ $0.86) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.